Troxerutin
Indication
1. It is suitable for hemiplegia, aphasia, pre-myocardial infarction syndrome, arteriosclerosis, central retinitis, thrombophlebitis, varicose veins, edema caused by increased vascular permeability, etc. caused by cerebral thrombosis and cerebral embolism; 2. It is suitable for hemiplegia, aphasia, arteriosclerosis, pre-infarction syndrome, thrombophlebitis, varicose veins, chronic venous insufficiency, central retinitis, diabetic retinitis, and edema caused by increased vascular permeability, etc. caused by cerebral thrombosis; 3. Clinical application shows that this product has a wide range of application and good efficacy, especially for the treatment of occlusive cerebrovascular disease.
Manufacturer
Shanxi Tongji Pharmaceutical Co., Ltd.
-
Founded in:
2007-03-16 -
Address:
Xikuang South Road, Ruicheng County, Yuncheng City, Shanxi Province -
Tax NO.:
911408006029340039 -
Registered Funds:
83.1 million yuan -
Website:
-
Email: